Fresh clinical trial results released Saturday by high-flying biopharma Amarin have confirmed the heart-protecting benefits of Vascepa, its prescription drug derived from fish oil, suggesting it could become a blockbuster therapy, potentially prescribed to millions of Americans.

The company said in September that its treatment significantly reduced the risk of cardiovascular events compared with a placebo. Detailed results from the trial, known as REDUCE-IT, showed Vascepa cut the risk of death, heart attack, and stroke — the three most important cardiovascular events — by 26 percent.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • i was cure of coronary artery disease (CAD) with the use of natural herbs.My name is Wilson from Zurich i was diagnosed with CAD (coronary artery disease in June of 2017.I was told i have only six months to live,i only believe the doctor for some time,then i took a bold step and I embarked on a journey when i saw a post by Charles and how he was cured by herbs by Dr Okpoko,so I contacted him and that was where i receive my healing.dr.Okpoko herbalist herbs cause a turning point in my life.since I have been on these African herbs drugs, i have been doing perfectly,no more heart disease all thanks to Dr Okpoko the great herbalist.if you are out there with the same disease or similar disease why not give him a try now on his email adamokpoko@gmail.com or call +2348151731392

  • I will start by saying to all that have CAD or IHD should please stop here and read up my story, So as you will know how to get your CURE. I had Coronary Heart Disease (CAD) for 15 years, My first symptoms were dry cough, chest tightness and shortness of breath. My first chest x-ray only showed bronchitis. and i was diagnosed with CAD, Am writing this article to appreciate the good work of Dr Adam herbal medicine, that helped me get read of my CAD/IHD that i have had for about 15years now, with no cure. After seeing a post of Carolina from UK on the internet testifying of how she was cured by Dr Adam herbal medicine prescribed remedies. I also decided to contact him for a cure and i purchased it because all i wanted was for me to get totally CURED, and to be free of it all my life. i Am happy today that they helped me and the herbal medicine worked and i can proudly say that i am free from CAD and i am cured completely its a worst thing to have CAD/IHD as a begin, if you are out there with the same disease or similar disease why not give him a try now on his email adamokpoko@gmail.com call or whatsapp on +2348151731392

  • It a new trend has come. First a company as Amarin advertises its project, makes hype. People are thinking that it’s rather useful. But in reality it is a dummy medicine.

  • It’s almost painful to realize that this Vascepa-hyping cuckoo train doesn’t stop. Amarin sure knows who and how much to pay to receive warm and cheerful reviews.

  • Chinese won just one Nobel prize, the scientist used a special way to extract the chemical from one special plant. Saved millions of life. Very similar, normal herbal way won’t work.

    • I think all this is total crap. Amarin puts on all sail to prove that Vascepa is able to fight against heart diseases for only one aim to raise the stock price.

    • I would call it more what a widespread of bribery and lack of ethics.
      And the FDA, allowing these kind of trials (including the one from Sage), screams utter incompetence and/or widespread corruption.

  • mineral oil?
    I could say that’s the dumbest thing I ever heard, but unfortunately it is not! I wonder who was the MD/FDA genius that authorized such use.
    Couldn’t they have used any edible oil? Or commonly used Omega-3 fish oil?
    Too afraid not to see any significant beneficial effect, I guess.

  • There is excitement suddenly over Vascepa (and Reduce IT) – over today’s data. But the scientific community has forgotten that the results at 60 & 80% (cardiovascular outcomes) were not equally encouraging, and the stock faltered below $3 (from $15).
    The present data is statistically powered and suddenly seem to give outstanding results!
    Hope the success of Vascepa is due to use of pure EPA?!!
    Let us ignore the use of mineral oil in placebo.
    Let us ignore the unsuccessful other fish-oil clinical trials.
    Let us ignore that the reduction of triglycerides do not have linear relationship with cardiovascular outcomes.
    Let us assume that mechanism is not important; and under the best case scenario – Vascepa might benefit millions of patients (there may be other uses too).
    At least investigator Dr. D. Bhatt, and Ceo J. Thero think it will be true blockbuster?
    Will it work wonders?

    • Thiru, Vascepa’s mode of action is many fold, pleiotropic if you will.
      Pure EPA is a potent ant-inflammatory which helps to reduce systemic
      inflammation in the body safely. Pure EPA also helps to heal lesions
      in arteries and strengthens the fibrous lining over plaques keeping them
      from rupturing. Vascepa will save many lives and prevent some of the
      most horrific CV events for patients that take it. The mineral oil placebo
      is chemically inert and safe. It was chosen in part because its color being
      clear matched the Vascepa capsules which are also clear. Had the study
      used corn oil or olive oil there would be concerns over those as well.
      My expectation is that Big Pharma will acquire AMRN as it is too massive
      a market for a small company to handle. Someday, the number of patients
      taking Vascepa will be in the 10’s of milions…but it will be with Big Pharma
      at the helm. Having loved ones on Vascepa for years now I have proof that
      they made a wise choice.

  • Dr. Gulati is wrong that there is no benefit for women. The benefit is
    indeed equal. One other point is that Vascepa is anti-inflammatory,
    it reduces systemic inflammation which is why it works even when
    Triglyceride levels are not reduced. Vascepa also heals lesions and
    strengthens the lining over arterial plaques. Vascepa will change the
    landscape in how CVD is treated.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy